Workarounds to reading a book cover-to-cover have existed for decades, but generative AI takes it to new heights. dem10/E+ via Getty Images AI is making reading books feel obsolete – and students have a lot to lose
Workarounds to reading a book cover-to-cover have existed for decades, but generative AI takes it to new heights. dem10/E+ via Getty Images
AI is making reading books feel obsolete – and students have a lot to lose
Naomi S. Baron, American University A perfect storm is brewing for reading. AI arrived as both kids and adults were already spending less time reading books than they did in the not-so-distant past. As a linguist, I study how technology influences the ways people read, write and think. This includes the impact of artificial intelligence, which is dramatically changing how people engage with books or other kinds of writing, whether it’s assigned, used for research or read for pleasure. I worry that AI is accelerating an ongoing shift in the value people place on reading as a human endeavor.
Everything but the book
AI’s writing skillshave gottenplenty of attention. But researchers and teachers are only now starting to talk about AI’s ability to “read” massive datasets before churning out summaries, analyses or comparisons of books, essays and articles. Need to read a novel for class? These days, you might get by with skimming through an AI-generated summary of the plot and key themes. This kind of possibility, which undermines people’s motivation to read on their own, prompted me to write a book about the pros and cons of letting AI do the reading for you. Palming off the work of summarizing or analyzing texts is hardly new. CliffsNotes dates back to the late 1950s. Centuries earlier, the Royal Society of London began producing summaries of the scientific papers that appeared in its voluminous “Philosophical Transactions.” By the mid-20th century, abstracts had become ubiquitous in scholarly articles. Potential readers could now peruse the abstract before deciding whether to tackle the piece in its entirety. The internet opened up an array of additional reading shortcuts. For instance, Blinkist is an app-based, subscription service that condenses mostly nonfiction books into roughly 15-minute summaries – called “Blinks” – that are available in both audio and text. But generative AI elevates such workarounds to new heights. AI-driven apps like BooksAI provide the kinds of summaries and analyses that used to be crafted by humans. Meanwhile, BookAI.chat invites you to “chat” with books. In neither case do you need to read the books yourself. If you’re a student asked to compare Mark Twain’s “The Adventures of Huckleberry Finn” with J. D. Salinger’s “The Catcher in the Rye” as coming-of-age novels, CliffsNotes only gets you so far. Sure, you can read summaries of each book, but you still must do the comparison yourself. With general large language models or specialized tools such as Google NotebookLM, AI handles both the “reading” and the comparing, even generating smart questions to pose in class. The downside is that you lose out on a critical benefit of reading a coming-of-age novel: the personal growth that comes from vicariously experiencing the protagonist’s struggles. In the world of academic research, AI offerings like SciSpace, Elicit and Consensus combine the power of search engines and large language models. They locate relevant articles and then summarize and synthesize them, slashing the hours needed to conduct literature reviews. On its website, Elsevier’s ScienceDirect AI gloats: “Goodbye wasted reading time. Hello relevance.” Maybe. Excluded from the process is judging for yourself what counts as relevant and making your own connections between ideas.
Reader unfriendly?
Even before generative AI went mainstream, fewer people were reading books, whether for pleasure or for class. In the U.S., the National Assessment of Educational Progress reported that the number of fourth graders who read for fun almost every day slipped from 53% in 1984 to 39% in 2022. For eighth graders? From 35% in 1984 to 14% in 2023. The U.K.’s 2024 National Literacy Trust survey revealed that only one in three 8- to 18-year-olds said they enjoyed reading in their spare time, a drop of almost 9 percentage points from just the previous year. Similar trends exist among older students. In a 2018 survey of 600,000 15-year-olds across 79 countries, 49% reported reading only when they had to. That’s up from 36% about a decade earlier. The picture for college students is no brighter. A spateof recent articles has chronicled how little reading is happening in American higher education. My work with literacy researcher Anne Mangen found that faculty are reducing the amount of reading they assign, often in response to students refusing to do it. Emblematic of the problem is a troubling observation from cultural commentator David Brooks:
“I once asked a group of students on their final day at their prestigious university what book had changed their life over the previous four years. A long, awkward silence followed. Finally a student said: ‘You have to understand, we don’t read like that. We only sample enough of each book to get through the class.’”
Now adults: According to YouGov, just 54% of Americans read at least one book in 2023. The situation in South Korea is even bleaker, where only 43% of adults said they had read at least one book in 2023, down from almost 87% in 1994. In the U.K., The Reading Agency observed declines in adult reading and hinted at one reason why. In 2024, 35% of adults identified as lapsed readers – they once read regularly, but no longer do. Of those lapsed readers, 26% indicated they had stopped reading because of time spent on social media. The phrase “lapsed reader” might now apply to anyone who deprioritizes reading, whether it’s due to lack of interest, devoting more time to social media or letting AI do the reading for you.
All that’s lost, missed and forgotten
Why read in the first place? The justifications are endless, as are the streams of books and websites making the case. There’s reading for pleasure, stress reduction, learning and personal development. You can find correlations between reading and brain growth in children, happiness, longevity and slowing cognitive decline. This last issue is particularly relevant as people increasingly let AI do cognitive work on their behalf, a process known as cognitive offloading. Research has emergedshowing the extent to which people are engaging in cognitive offloading when they use AI. The evidence reveals that the more users rely on AI to perform work for them, the less they see themselves as drawing upon their own thinking capacities. A study employing EEG measurements found different brain connectivity patterns when participants enlisted AI to help them write an essay than when writing it on their own. It’s too soon to know what effects AI might have on our long-term ability to think for ourselves. What’s more, the research so far has largely focused on writing tasks or general use of AI tools, not on reading. But if we lose practice in reading and analyzing and formulating our own interpretations, those skills are at risk of weakening. Cognitive skills aren’t the only thing at stake when we rely too heavily on AI to do our reading work for us. We also miss out on so much of what makes reading enjoyable – encountering a moving piece of dialogue, relishing a turn of phrase, connecting with a character. AI’s lure of efficiency is tantalizing. But it risks undermining the benefits of literacy. Naomi S. Baron, Professor Emerita of Linguistics, American University This article is republished from The Conversation under a Creative Commons license. Read the original article.
Harkins Theatres Announces Rob Reiner Tribute Screening on December 17
Rob Reiner Tribute: Harkins Theatres will host a special $5 screening of The American President on December 17 to honor filmmaker Rob Reiner, with all proceeds benefiting the Human Rights Campaign.
Harkins Theatres Announces Rob Reiner Tribute Screening of The American President
Harkins Theatres has announced a special one-day tribute screening honoring acclaimed filmmaker Rob Reiner, celebrating his life’s work and cinematic legacy.
On December 17, select Harkins locations will screen Reiner’s 1995 political romance The American President, with all proceeds benefiting the Human Rights Campaign. Tickets are priced at $5, making the event both an accessible film experience and a charitable fundraiser.
The tribute was announced via Harkins’ official, verified social media accounts and is positioned as a legacy celebration, not a memorial.
🎥 Why The American President?
Released in 1995 and written by Aaron Sorkin, The American President stars Michael Douglas and Annette Bening and remains one of Rob Reiner’s most politically resonant films. The movie blends romance, idealism, and civic responsibility — themes that have consistently appeared throughout Reiner’s career.
The film later served as a creative blueprint for The West Wing, cementing its place in modern political storytelling.
Rob Reiner’s career spans more than five decades, including landmark films such as:
This Is Spinal Tap
Stand By Me
The Princess Bride
When Harry Met Sally…
Misery
A Few Good Men
His work is often praised for balancing entertainment, empathy, and social conscience, making tribute events like this especially meaningful to longtime audiences.
Hollywood Legend Rob Reiner and Wife Found Dead; Son in Custody
Renowned filmmaker Rob Reiner and his wife, Michele Singer Reiner, were found dead in their Los Angeles home in a reported homicide. Police have arrested their son in connection with the case, and tributes are pouring in.
Director Rob Reiner participates in a discussion following a screening of the film LBJ at the LBJ Presidential Library in Austin, Texas on Saturday October 22, 2016 On Saturday evening October 22, 2016, the LBJ Presidential Library held a sneak peek of Rob Reiner’s new filmÊLBJ, starring Woody Harrelson as the 36th president. The film, which premiered at the Toronto International Film Festival in September, chronicles the life and times of Lyndon Johnson who would inherit the presidency at one of the most fraught moments in American history. Following the screening, director Rob Reiner, actor Woody Harrelson, and writer Joey Hartstone joined LBJ Library Director Mark Updegrove on stage for a conversation about the film. LBJ Library photo by Jay Godwin 10/22/2016
Hollywood Legend Rob Reiner and Wife Found Dead; Son in Custody
December 15, 2025
Renowned filmmaker and actor Rob Reiner, 78, and his wife Michele Singer Reiner, 68, were found dead in their Brentwood, Los Angeles home on Sunday, authorities say. Emergency responders were called to the residence Sunday afternoon, where both were discovered with fatal wounds consistent with a stabbing. Police are treating the case as a double homicide.
Los Angeles police arrested the couple’s 32-year-old son, Nick Reiner, in connection with the deaths. He is being held in custody as investigators continue to piece together the circumstances surrounding the incident.
2016 SAMHSA Voice Awards
Reiner was one of Hollywood’s most influential figures, known for his work as a director, producer and actor. His career spanned decades, from early television fame to directing beloved films that shaped American cinema.
Friends, colleagues and public figures have begun sharing tributes and reactions to the news as the investigation is ongoing.
More details will be updated as they become available.
FDA’s COVID-19 Vaccine Safety Claims Lack Solid Evidence—Why Overreaction Could Harm Public Health
COVID-19 vaccine safety: The FDA’s claims about COVID-19 vaccine deaths in children lack strong evidence and could restrict vaccine access. Learn why experts say VAERS reports aren’t proof, and how overreacting may harm public health and trust in vaccines.
The death of children due to an unsafe vaccine is a serious allegation. I am a pediatric cardiologist who has studied the link between COVID-19 vaccines and heart-related side effects such as myocarditis in children. To my knowledge, studies to date have shown such side effects are rare, and severe outcomes even more so. However, I am open to new evidence that could change my mind. But without sufficient justification and solid evidence, restricting access to an approved vaccine and changing well-established procedures for testing vaccines would carry serious consequences. These moves would limit access for patients, create roadblocks for companies and worsen distrust in vaccines and public health. In my view, it’s important for people reading about these FDA actions to understand how the evidence on a vaccine’s safety is generally assessed.
Determining cause of death
The FDA memo claims that the deaths of these children were directly related to receiving a COVID-19 immunization. From my perspective as a clinician, it is awful that any child should die from a routine vaccination. However, health professionals like me owe it to the public to uphold the highest possible standards in investigating why these deaths occurred. If the FDA has evidence demonstrating something that national health agencies worldwide have missed – widespread child deaths due to myocarditis caused by the COVID-19 vaccine – I don’t doubt that even the most pro-vaccine physician will listen. So far, however, no such evidence has been presented. While a death logged in VAERS is a starting point, on its own it is insufficient to conclude whether a vaccine caused the death or other medical causes were to blame. To demonstrate a causal link, FDA staff and physicians must align the VAERS report with physicians’ assessments of the patient, as well as data from other sources for monitoring vaccine safety. These include PRISM, which logs insurance claims data, and the Vaccine Safety Datalink, which tracks safety signals in electronic medical records. It’s known that most deaths logged only in VAERS of children who recently received vaccines have been incorrectly attributed to the vaccines – either by accident or in some cases on purpose by anti-vaccine activists.
Heart-related side effects of COVID-19 vaccines
In his Substack and Twitter accounts, Prasad has said that he believes the rate of severe cardiac side effects after COVID-19 vaccination is severely underestimated and that the vaccines should be restricted far more than they currently are. In a July 2025 presentation, Prasad quoted a risk of 27 cases per million of myocarditis in young men who received the COVID-19 vaccine. A 2024 review suggested that number was a bit lower – about 20 cases out of 1 million people. But that same study found that unvaccinated people had greater risk of heart problems after a COVID-19 infection than vaccinated people. In a different study, people who got myocarditis after a COVID-19 vaccination developed fewer complications than people who got myocarditis after a COVID-19 infection. Existing vaccine safety infrastructure in the U.S. successfully identifies dangers posed by vaccines – and did so during the COVID-19 pandemic. Today, most COVID-19 vaccines in the U.S. rely on mRNA technology. But as vaccines were first emerging during the COVID-19 pandemic, two pharmaceutical companies, Janssen and AstraZeneca, rolled out a vaccine that used a different technology, called a viral vector. This type of vaccine had a very rare but genuine safety problem that was detected.A report in VAERS is at most a first step to determining whether a vaccine caused harm. VAERS, the Vaccine Safety Datalink, clinical investigators in the U.S. and their European counterparts detected that these vaccines did turn out to cause blood clotting. In April 2021, the FDA formally recommended pausing their use, and they were later pulled from the market. Death due to myocarditis from COVID-19 vaccination is exceedingly rare. Demonstrating that it occurred requires proof that the person had myocarditis, evidence that no other reasonable cause of death was present, and the absence of any additional cause of myocarditis. These factors cannot be determined from VAERS data, however – and to date, the FDA has presented no other relevant data.
A problematic vision for future vaccine approvals
Currently, vaccines are tested both by seeing how well they prevent disease and by how well they generate antibodies, which are the molecules that help your body fight viruses and bacteria. Some vaccines, such as the COVID-19 vaccine and the influenza vaccine, need to be updated based on new strains. The FDA generally approves these updates based on how well the new versions generate antibodies. Since the previous generation of vaccines was already shown to prevent infection, if the new version can generate antibodies like the previous one, researchers assume its ability to prevent infection is comparable too. Later studies can then test how well the vaccines prevent severe disease and hospitalization. The FDA memo says this approach is insufficient and instead argues for replacing such studies with many more placebo-controlled trials – not just for COVID-19 vaccines but also for widely used influenza and pneumonia vaccines. That may seem reasonable theoretically. In practice, however, it is not realistic. Today’s influenza vaccines must be changed every season to reflect mutations to the virus. If the FDA were to require new placebo-controlled trials every year, the vaccine being tested would become obsolete by the time it is approved. This would be a massive waste of time and resources.Influenza vaccines must be updated for every flu season.Jacob Wackerhausen/iStock via Getty Images Plus Also, detecting vaccine-related myocarditis at the low rate at which it occurs would have required clinical trials many times larger than the ones that were done to approve COVID-19 mRNA vaccines. This would have cost at least millions of dollars more, and the delay in rolling out vaccines would have also cost lives. Placebo-controlled trials would require comparing people who receive the updated vaccine with people who remain unvaccinated. When an older version of the vaccine is already available, this means purposefully asking people to forgo that vaccine and risk infection for the sake of the trial, a practice that is widely considered unethical. Current scientific practice is that only a brand-new vaccine may be compared against placebo. While suspected vaccine deaths should absolutely be investigated, stopping a vaccine for insufficient reasons can lead to a significant drop in public confidence. That’s why it’s essential to thoroughly and transparently investigate any claims that a vaccine causes harm.
